サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1753953

腹膜透析市場レポート：治療タイプ別、製品別、エンドユーザー別、地域別、2025年～2033年

Peritoneal Dialysis Market Report by Treatment Type (Continuous Ambulatory Peritoneal Dialysis, Automated Peritoneal Dialysis ), Product, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 141 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.06円
腹膜透析市場レポート：治療タイプ別、製品別、エンドユーザー別、地域別、2025年～2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

腹膜透析の世界市場規模は2024年に180億米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに265億米ドルに達し、2025～2033年の成長率（CAGR）は4.16%になると予測しています。この市場を牽引しているのは、世界の透析センター数の増加、腎臓病管理を推進する政府のイニシアティブの高まり、持続的外来透析（CAPD）の採用拡大、新興国におけるヘルスケアインフラの拡大などです。現在、北米が最大の腹膜透析市場シェアを占めているが、これは有利な償還政策と高齢者人口の増加によるものです。

腹膜透析（PD）は腎不全治療法の一種であり、手術によって柔らかいプラスチック製のチューブやカテーテルを腹腔内やお腹に留置します。カテーテルが留置されると、無菌の洗浄液がカテーテル管から送り込まれ、老廃物を除去して体内の血液をろ過します。一定時間後、液体と濾過された不要成分は腹部から流出し、廃棄されます。PDは、持続的外来療法（腹膜透析）と持続的循環療法（CCPD）に区別されます。これらの方法は、治療の柔軟性を提供し、透析センターに通う必要性を減らし、より良い臨床結果をもたらし、その結果、投薬量や食事制限が少なくなります。これとは別に、自宅で実施でき、針を使用しないため、PDは病院やヘルスケアセンターで腎不全の治療に使用されています。

腹膜透析市場動向：

末期腎不全（ESRD）の有病率の増加

末期腎不全（ESRD）の有病率の増加は、腹膜透析の世界市場成長を促進する重要な要因です。ESRD患者が生存するためには、透析または腎移植が必要であり、腹膜透析はその利便性と在宅医療という性質から、好ましい治療法として台頭してきています。米国腎データシステムによると、2015年の新規ESRD診断件数は12万4,411件で、年間約2万件のペースで増加しています。ESRDの症例数が世界的に増加し続ける中、腹膜透析を含む効果的で利用しやすい透析オプションへの需要が高まっています。この動向は、透析技術の進歩によってさらに後押しされ、拡大するESRD患者のヘルスケアニーズの高まりに応えています。

糖尿病と高血圧の増加

糖尿病と高血圧の増加は、慢性腎臓病（CKD）と末期腎臓病（ESRD）の主な原因であるため、腹膜透析市場シェアの拡大に寄与する重要な要因です。糖尿病と高血圧はいずれも血管を損傷し、時間の経過とともに腎機能を低下させ、最終的には生存のために透析や腎移植を必要とします。糖尿病と高血圧の世界の有病率の上昇に伴い、特に高齢化社会では腎不全の症例が増加しています。その結果、腹膜透析を含む様々な透析治療に対する需要が高まっており、腹膜透析市場の成長に拍車をかけています。この種の透析は、患者にとって便利な在宅ソリューションを提供するため、こうした一般的な健康状態に関連する腎不全の管理に好ましい選択肢となっています。

ヘルスケア支出の増加

ヘルスケア支出の増加も、高度な透析治療への幅広いアクセスを可能にする一方で、市場を牽引しています。先進諸国を中心に世界的にヘルスケア支出が増加するにつれて、腎不全のような慢性疾患の管理により多くの資金が割り当てられています。このため、インフラの改善、より良い訓練を受けた医療従事者、最先端の腹膜透析技術へのアクセスが可能になります。さらに、腹膜透析市場分析レポートによると、ヘルスケア予算の増加により、センター内の血液透析に比べて費用対効果が高く、利便性の高い在宅治療の導入が促進されています。また、長期的な透析医療をサポートする政府プログラムや保険政策も世界各国で整ってきており、患者の経済的負担が軽減され、包括的なヘルスケアシステムの一部として、利用しやすく質の高い腹膜透析ソリューションの需要が高まっています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の腹膜透析市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：治療タイプ別

  • 持続歩行腹膜透析（CAPD）
  • 自動腹膜透析（APD）

第7章 市場内訳：製品別

  • 腹膜透析ソリューション
  • 腹膜透析デバイス
  • 腹膜透析セット
  • 腹膜透析カテーテル
  • その他

第8章 市場内訳：エンドユーザー別

  • 在宅透析
  • 透析センターと病院ベースの透析

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Amecath
    • Baxter International Inc.
    • Fresenius Medical Care AG & Co. KGaA
    • Medical Components Inc.
    • Medionics International Inc.
    • Medtronic plc
    • Merit Medical Systems Inc.
    • Mitra Industries Pvt. Ltd.
    • Newsol Technologies Inc.
    • Nipro Canada（Nipro Medical Corporation）
    • Poly Medicure Limited
    • Terumo Corporation
    • Utah Medical Products Inc.
図表

List of Figures

  • Figure 1: Global: Peritoneal Dialysis Market: Major Drivers and Challenges
  • Figure 2: Global: Peritoneal Dialysis Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Peritoneal Dialysis Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Peritoneal Dialysis Market: Breakup by Treatment Type (in %), 2024
  • Figure 5: Global: Peritoneal Dialysis Market: Breakup by Product (in %), 2024
  • Figure 6: Global: Peritoneal Dialysis Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Peritoneal Dialysis Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Peritoneal Dialysis (Automated Peritoneal Dialysis (APD)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Peritoneal Dialysis (Automated Peritoneal Dialysis (APD)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Peritoneal Dialysis (Peritoneal Dialysis Solution) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Peritoneal Dialysis (Peritoneal Dialysis Solution) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Peritoneal Dialysis (Peritoneal Dialysis Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Peritoneal Dialysis (Peritoneal Dialysis Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Peritoneal Dialysis (Peritoneal Dialysis Sets) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Peritoneal Dialysis (Peritoneal Dialysis Sets) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Peritoneal Dialysis (Peritoneal Dialysis Catheters) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Peritoneal Dialysis (Peritoneal Dialysis Catheters) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Peritoneal Dialysis (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Peritoneal Dialysis (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Peritoneal Dialysis (Home-based Dialysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Peritoneal Dialysis (Home-based Dialysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Peritoneal Dialysis (Dialysis Centers and Hospital-based Dialysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Peritoneal Dialysis (Dialysis Centers and Hospital-based Dialysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Peritoneal Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Peritoneal Dialysis Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Peritoneal Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Peritoneal Dialysis Industry: SWOT Analysis
  • Figure 76: Global: Peritoneal Dialysis Industry: Value Chain Analysis
  • Figure 77: Global: Peritoneal Dialysis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Peritoneal Dialysis Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Peritoneal Dialysis Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
  • Table 3: Global: Peritoneal Dialysis Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 4: Global: Peritoneal Dialysis Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Peritoneal Dialysis Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Peritoneal Dialysis Market: Competitive Structure
  • Table 7: Global: Peritoneal Dialysis Market: Key Players
目次
Product Code: SR112025A6545

The global peritoneal dialysis market size reached USD 18.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 26.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.16% during 2025-2033. The market is being driven by the rising number of dialysis centers worldwide, the increasing government initiatives to promote kidney disease management, the growing adoption of continuous ambulatory peritoneal dialysis (CAPD), and the expanding healthcare infrastructure in developing countries. At present, North America holds the largest peritoneal dialysis market share, driven by favorable reimbursement policies and the rising geriatric population.

Peritoneal dialysis (PD) represents a type of kidney failure treatment procedure wherein a soft plastic tube or catheter is placed in the abdominal lining or belly through surgery. Once it is positioned, a sterile cleansing fluid is transmitted by the duct that helps filter the blood inside an individual's body by removing waste products. After a period of time, the liquid and filtered unwanted components flow out of the abdomen and are discarded. PD is differentiated into continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis (CCPD). These approaches offer treatment flexibility, reduce the need to visit dialysis centers, and provide better clinical outcomes, resulting in lesser medications and fewer food restrictions. Apart from this, it can be carried out at home and is needle-free; thus, PD is used by hospitals and healthcare centers to treat kidney failures.

Peritoneal Dialysis Market Trends:

Growing prevalence of end-stage renal disease (ESRD)

The growing prevalence of end-stage renal disease (ESRD) is a key factor driving the global peritoneal dialysis market growth as ESRD patients require dialysis or kidney transplantation to survive, with peritoneal dialysis emerging as a preferred treatment due to its convenience and home-based nature. According to the United States Renal Data System, there were 124,411 new ESRD diagnoses in 2015, with the disease increasing at about 20,000 cases per year. As the number of ESRD cases continues to rise globally, the demand for effective and accessible dialysis options, including peritoneal dialysis, increases. This trend is further supported by advancements in dialysis technologies, helping to meet the growing healthcare needs of the expanding ESRD population.

Increasing incidences of diabetes and hypertension

The rising incidences of diabetes and hypertension are significant drivers contributing to the augmenting peritoneal dialysis market share, as these conditions are the leading causes of chronic kidney disease (CKD) and end-stage renal disease (ESRD). Both diabetes and hypertension damage blood vessels and reduce kidney function over time, ultimately requiring dialysis or kidney transplantation for survival. With the global prevalence of diabetes and hypertension on the rise, particularly in aging population, there has been a corresponding increase in kidney failure cases. As a result, the demand for various dialysis treatments, including peritoneal dialysis, is escalating, thereby impelling the peritoneal dialysis market growth. This type of dialysis offers a convenient, home-based solution for patients, making it a preferred choice for managing kidney failure linked to these common health conditions.

Rising healthcare expenditures

Rising healthcare expenditures are also driving the market while enabling broader access to advanced dialysis treatments. As healthcare spending increases globally, especially in developed countries, more funds are allocated to managing chronic diseases like kidney failure. This allows for improved infrastructure, better-trained medical professionals, and access to cutting-edge peritoneal dialysis technologies. Additionally, according to the peritoneal dialysis market analysis report, increased healthcare budgets facilitate the adoption of home-based treatments, which can be more cost-effective and convenient compared to in-center hemodialysis. Government programs and insurance policies are also better positioned across numerous countries across the globe to support long-term dialysis care, thus easing the financial burden on patients and driving the demand for accessible, quality peritoneal dialysis solutions as part of comprehensive healthcare systems.

Peritoneal Dialysis Market Segmentation:

Breakup by Treatment Type:

  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • Automated Peritoneal Dialysis (APD)

Breakup by Product:

  • Peritoneal Dialysis Solution
  • Peritoneal Dialysis Devices
  • Peritoneal Dialysis Sets
  • Peritoneal Dialysis Catheters
  • Others

Breakup by End User:

  • Home-based Dialysis
  • Dialysis Centers and Hospital-based Dialysis

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global peritoneal dialysis market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

  • Amecath
  • Baxter International Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Medical Components Inc.
  • Medionics International Inc.
  • Medtronic plc
  • Merit Medical Systems Inc.
  • Mitra Industries Pvt. Ltd.
  • Newsol Technologies Inc.
  • Nipro Canada (Nipro Medical Corporation)
  • Poly Medicure Limited
  • Terumo Corporation
  • Utah Medical Products Inc.

Key Questions Answered in This Report:

  • How has the global peritoneal dialysis market performed so far, and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global peritoneal dialysis market?
  • What are the key regional markets?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global peritoneal dialysis market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Peritoneal Dialysis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Treatment Type

  • 6.1 Continuous Ambulatory Peritoneal Dialysis (CAPD)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Automated Peritoneal Dialysis (APD)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Peritoneal Dialysis Solution
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Peritoneal Dialysis Devices
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Peritoneal Dialysis Sets
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Peritoneal Dialysis Catheters
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Home-based Dialysis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Dialysis Centers and Hospital-based Dialysis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Amecath
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Baxter International Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Fresenius Medical Care AG & Co. KGaA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Medical Components Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Medionics International Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Medtronic plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Merit Medical Systems Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Mitra Industries Pvt. Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Newsol Technologies Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Nipro Canada (Nipro Medical Corporation)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Poly Medicure Limited
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Terumo Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Utah Medical Products Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials